We hope that the peptide drug developed in this study could be a viable option for second-line adjuvant tumor therapy
These structural changes allow researchers to investigate sustained activation of amylin-related signaling pathways
While cognitive resilience is an emerging research domain, the mechanisms driving cognitive frailty (chronic cognitive decline in absence of measurable neuropathology) are less well described
It is not approved for use as a drug, food, cosmetic, or medical product and is not intended for human or animal consumption
Sold for laboratory and research applications
Many patients combine peptide therapy with PRP/PRF treatments for hair restoration or skin rejuvenation, NAD+ therapy for cellular energy and longevity support, hormone optimization for comprehensive wellness, and microneedling with growth factors for skin healing